Predict your next investment

Corporation
HEALTHCARE | Drug Development
inviragen.com

See what CB Insights has to offer

Total Raised

$15M

Investors Count

5

Deal Terms

2

Inviragen Funding, Inviragen Valuation & Inviragen Revenue

2 Fundings

Inviragen's latest funding round was a Acquired for on May 8, 2013.

Inviragen's latest post-money valuation is from May 2013.

Sign up for a free 30-day trial to see Inviragen's valuations in May 2013 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/8/2013

Acquired

$99M

$0.00B

((9.99x))

FY 1234

1

10/22/2009

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

Date

5/8/2013

10/22/2009

Round

Acquired

Series A

Amount

$99M

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

Inviragen Deal Terms

2 Deal Terms

Inviragen's deal structure is available for 2 funding rounds, including their Acquired from May 08, 2013.

Round

Acquired

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Series A

Inviragen Investors

5 Investors

Inviragen has 5 investors. Takeda Pharmaceutical invested in Inviragen's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

5/8/2013

5/8/2013

1
Acquired

Corporation

Japan

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Asset/Investment Management

Singapore

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Wisconsin

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Investment Bank

Australia

First funding

5/8/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

5/8/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Corporation

Asset/Investment Management

Venture Capital

Venture Capital

Investment Bank

Location

Japan

Singapore

Wisconsin

California

Australia

Inviragen Acquisitions

1 Acquisition

Inviragen acquired 1 company. Their latest acquisition was SingVax on October 05, 2009.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/5/2009

Merger

1

Date

10/5/2009

Investment Stage

Companies

Valuation

Total Funding

Note

Merger

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.